Morphine exposure in early life increases nociceptive behavior in a rat formalin tonic pain model in adult life.
Considering the importance of a deeper understanding of the effect throughout life of opioid analgesia at birth, our objective was to determine whether morphine administration in early life, once a day for 7 days in 8-day-old rats, alters the nociceptive response over the short (P16), medium (P30), and long term (P60) and to evaluate which system is involved in the altered nociceptive response. The nociceptive responses were assessed by the formalin test, and the behavior analyzed was the total time spent in biting and flicking of the formalin-injected hindpaw, recorded during the first 5 min (phase I) and from 15-30 min (phase II). The morphine group showed no change in nociceptive response at P16, but at P30 and P60, the nociceptive response was increased in phase I, and in both phases, respectively. At P30 and P60, the animals received a non-steroidal anti-inflammatory drug (indomethacin) or NMDA receptor antagonist (ketamine) 30 min before the formalin test. The increase in the nociceptive response was completely reversed by ketamine, and partially by indomethacin. These results indicate that early morphine exposure causes an increase in the nociceptive response in adult life. It is possible that this lower nociception threshold is due to neuroadaptations in nociceptive circuits, such as the glutamatergic system. Thus, this work demonstrates the importance of evaluating clinical consequences related to early opioid administration and suggests a need for a novel design of agents that may counteract opiate-induced neuroplastic changes.
Rozisky
Joanna Ripoll
JR
Programa de Pós-Graduação em Medicina, Ciências Médicas, Universidade Federal do Rio Grande do Sul, CEP 90035-003, Porto Alegre, Brazil.
Medeiros
Liciane Fernandes
LF
Adachi
Lauren Spezia
LS
Espinosa
Janaína
J
de Souza
Andressa
A
Neto
Alberto Sette
AS
Bonan
Carla Denise
CD
Caumo
Wolnei
W
Torres
Iraci Lucena da Silva
IL
D000367:Age Factors; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000704:Analysis of Variance; D000778:Anesthetics, Dissociative / Q000008:administration & dosage; D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000187:drug effects*; D004195:Disease Models, Animal; D005557:Formaldehyde / Q000009:adverse effects*; D007649:Ketamine / Q000008:administration & dosage; D008297:Male; D009020:Morphine / Q000008:administration & dosage* / Q000627:therapeutic use*; D010146:Pain / Q000139:chemically induced* / Q000188:drug therapy*; D010147:Pain Measurement / Q000379:methods; D051381:Rats; D017208:Rats, Wistar
D000701:Analgesics, Opioid; D000778:Anesthetics, Dissociative; D005557:Formaldehyde; D007649:Ketamine; D009020:Morphine